Support our Foundation of Myology project
1670 news items
Lamotrigine appears to be effective over two years in channelopathies
On 16/02/2026
Used as an alternative to mexiletine in the treatment of non-dystrophic myotonia, lamotrigine shows lasting efficacy in a new British study: it involved 37 patients…
ERN EURO-NMD webinar, 19 Feb.: Dr. Marcella Ner (Italy)
On 13/02/2026
Genetics Month episode 3: Genetics of Amyotrophic Lateral Sclerosis and Impact on New Therapies Thursday 19 February 2026 – 16:00-17:00 Paris time Dr. Marcella Neri…
Intrathecal gene therapy Itvisma effective in two Phase III trials in SMA
On 13/02/2026
In SMN1-related proximal spinal muscular atrophy (SMA), the intravenous treatment Zolgensma is indicated for infants and young children weighing less than 21 kg with type…
Full speed ahead to the 4th Muscle Week and the 2026 Muscle Conference!
On 12/02/2026
The Winter Olympic Games offer a timely reminder of a fundamental truth: muscle is not only responsible for athletic prowess and sporting performance, it is, above all, a major public health issue. By interacting with many organs,…
The Institute acquires a new, latest-generation multimodal confocal microscope
On 12/02/2026
Bruno Cadot, researcher at the Center of Research in Myology and head of the MyoImage technology platform, oversaw the acquisition of a latest-generation Nikon AXR-NSPARC confocal…
ERN EURO-NMD webinar, 12 Feb.: Dr. Fernanda Fortunato (Italy)
On 09/02/2026
Genetics Month episode 2: CPMS Use and Value for Genetic Case Discussions Thursday, 12 February 2026 – 16:00-17:00 Paris time Dr. Fernanda Fortunato (University Hospital…
Effects of exoskeletons on mobility and motor function in MND patients
On 05/02/2026
Neuromuscular diseases (NMDs) cause progressive muscle weakness that significantly impairs patients’ functional abilities and quality of life. Romain Feigean, researchers in Neuromuscular Physiology and Evaluation…
A new FDX2 mutation identified in a form of mitochondrial myopathy
On 05/02/2026
An Italian team studied the case of a 9-year-old patient with a mitochondrial myopathy called MEOAL (Mitochondrial Episodic Myopathy with or without Optic Atrophy and…
French study identifies prognostic markers for interstitial lung disease associated with anti-synthase syndrome
On 04/02/2026
Conducted in seven reference or competence centres in north-eastern France, the TYPASS retrospective study included 132 adults with antisynthetase syndrome and interstitial lung disease: 39%…
Positive results from the Phase III SAPPHIRE trial with apitegromab in SMA
On 02/02/2026
Apitegromab is a human monoclonal antibody that selectively inhibits myostatin activation to improve muscle function. Its efficacy was evaluated at one year in the Phase…
Feedback on inflammatory myositis in the African population of Martinique
On 30/01/2026
Clinicians in Martinique report on their experience in the field of inflammatory myopathies occurring in the Caribbean population of African origin: the records of 174…
Evrysdi, reimbursed for presymptomatic SMA
On 29/01/2026
According to the publication in the Official Journal of 13 January 2026, the conditions for reimbursement of Evrysdi (Risdiplam) in oral solution form have been…
Is rituximab useful in ocular myasthenia gravis?
On 29/01/2026
Chinese clinicians report encouraging results regarding the use of rituximab, an anti-CD20 monoclonal antibody, in forms of ocular myasthenia gravis: their pilot study involved 9…
“Michel Fardeau, a life under the microscope”: testimony from a pioneer in myology
On 28/01/2026
The French Society of Myology (SFM) has published « Michel Fardeau, a life under the microscope », a beautiful book (in French) dedicated to the founding father…
An unprecedented paediatric case of myopathy linked to the HMGCR gene
On 28/01/2026
HMGCR is an enzyme involved in the metabolism of cholesterol and other metabolites. Until now, it was best known in connection with autoimmune necrotising myopathy…
A rare form of myosinopathy now better understood
On 27/01/2026
Researchers at the Institute of Myology* compiled clinical and genetic data from 13 patients who were found to have pathologic variants of the MYH2 gene:…
A comprehensive study of a series of patients with SLONM
On 26/01/2026
Italian clinicians analysed the clinical and biological data from a large series of cases of sporadic late-onset nemaline myopathy (SLONM): they added their own cases…
The utility of the national Pompe disease registry in understanding causes of death and comorbidities
On 26/01/2026
The French Pompe disease registry, which includes 200 patients, is an unrivalled source of clinical and biological data that provides a better understanding of the…
A comparative analysis of long-read sequencing techniques in two neuromuscular diseases
On 22/01/2026
In collaboration with their Japanese colleagues, researchers from the Myology Institute* compared the diagnostic use of new sequencing technologies in the context of a growing…
M&M’s – Muscle Monday Seminar – 26 Jan. – Dr Metodi Metodiev (France)
On 21/01/2026
Mitochondrial diseases: pathogenesis and cure 26 January 2026 from noon to 1pm (Paris time) Dr Metodi METODIEV (Institut Imagine, Paris) Invited by Marc Bitoun More information on the…
